The Trendlines Group Ltd. (42T.SI) Stock

About The Trendlines Group Ltd.

The Trendlines Group Ltd. is a private equity and venture capital firm focused on commercializing innovative technologies. They specialize in early-stage investments, ranging from incubation and seed funding to start-up and even later-stage venture capital for more established companies. Their investment strategy targets high-growth sectors such as food, medical technology (medtech), clean technology, agrifood, agritechnology, and life sciences, specifically emphasizing medical devices, biotechnology, and pharmaceuticals. They also consider opportunities in security, general medical fields, and information technology. The firm primarily seeks to invest in companies located in Israel and Singapore. Beyond financial backing, Trendlines offers extensive support to entrepreneurs, encompassing business incubation, market strategy development, research and development guidance, commercialization services, business development, funding strategies, administrative assistance, and marketing communications. The preferred exit routes for their investments include mergers and acquisitions, public stock listings, or other strategic dispositions of holdings. To mitigate the risks inherent in developing new businesses, Trendlines leverages its own capital alongside government funding. The firm actively participates in all aspects of its portfolio companies, from technological innovation to comprehensive business construction. Founded in 1993, The Trendlines Group Ltd. is headquartered in M.P. Misgav, Israel, and maintains additional offices in Tel Aviv, Israel; Beijing, China; and Singapore.

The Trendlines Group Ltd. is led by CEO Haim Brosh, employs 20 people, headquartered in M P Misgav, IL, publicly traded since 2015.

over the past 52 weeks the stock has ranged between $0.03 and $0.08, and currently trades 25.0% below its 52-week high.

Official website: www.trendlines.com